by Shana Cristoferi | Dec 16, 2020 | News, SONA NanoTech
Read Orginal Article Here December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement...
by Shana Cristoferi | Jul 5, 2020 | News, SONA NanoTech
Read original here Shares of Halifax-based Sona Nanotech more than doubled Friday after the nanoparticle technology company said clinical trials showed its COVID-19 rapid testing kit has a 96 percent sensitivity to the virus. The company’s shares on the Canadian Stock...
by Shana Cristoferi | Jun 28, 2019 | News, SONA NanoTech
See full Entrevestor article here by Darren Rowles, CEO of Sona Nanotech | Among the many positive headlines, facts and figures about Halifax contained in the latest edition of the Halifax Index is a particular statistic that caught my attention. New research by the...
by Shana Cristoferi | Jun 27, 2019 | Appili Therapeutics, IMV Inc., News, SONA NanoTech
Read full Entrevestor article here The stock market is looming larger in the Atlantic Canadian startup community than it ever has before, as several leading companies are choosing public markets as the best option to secure long-term financing. Just in the past week,...
by administrator | Jan 16, 2019 | News, SONA NanoTech
Read original release here Innovative companies combine technologies to speed up lateral flow assay development time Halifax, Nova Scotia–(Newsfile Corp. – January 16, 2019) – Sona Nanotech Inc. (CSE: SONA) today announced a collaboration with Australia-based nanotech...
by administrator | Dec 4, 2018 | News, SONA NanoTech
Read the original press release here Halifax, Nova Scotia–(Newsfile Corp. – December 4, 2018) – Sona Nanotech Inc. (CSE: SONA) has signed a collaboration agreement with one of Europe’s largest lateral flow test developers, who will integrate Sona’s nanorod technology...
